Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma [Phase 2]
Phase II study evaluating short-term cultured autologous anti-tumor lymphocytes after lymphocyte-depleting chemotherapy in metastatic melano…
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV [Phase 2]
A Phase 2 study evaluating the combination of temsirolimus and AZD6244 (selumetinib) in treatment-naive patients with BRAF-mutant unresectab…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating SB-715992 for metastatic or recurrent malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating temsirolimus and bryostatin-1 in patients with unresectable or metastatic solid tumors, including recurrent melanom…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial update reports results from evaluating pegylated arginine deiminase (ADI-PEG 20) in patients with metastatic melanoma tha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer [Phase 1]
Phase 1 trial evaluating Yttrium-90 SMT-487 in patients with refractory or recurrent cancers across multiple tumor types; the study has comp…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma [Phase 2]
A Phase 2 pilot trial evaluating a 'Chemo-Switch' regimen for advanced melanoma was terminated, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Rituximab in Metastatic Melanoma [Phase 1]
Phase 1 trial of rituximab in metastatic melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Immunotherapy of Melanoma Patients [Phase 1]
A Phase 1 immunotherapy trial for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients [Phase 1]
This entry reports the completion of a Phase 1 trial evaluating immunotherapy in HLA-A2 positive patients with stage III/IV melanoma.
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
This trial update covers a monoclonal antibody therapy tested in patients with stage III or stage IV melanoma in Phase 1/2 trials, which has…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
This Phase 2 trial assessed a combination of cyclophosphamide, fludarabine, and high-dose interleukin-2 in metastatic melanoma; the study is…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating temozolomide in combination with bevacizumab for stage IV melanoma that cannot be surgically removed has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Tanespimycin in Treating Patients With Stage III-IV Melanoma [Phase 2]
A Phase 2 trial of Tanespimycin in patients with stage III-IV melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a biological therapy after surgery in patients with stage III or stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma [Phase 1]
Phase 1 clinical trial update reporting completion of a study evaluating fludarabine followed by vaccine therapy and white blood cell infusi…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
This is a Phase 2 clinical trial evaluating a conditioning regimen of cyclophosphamide, fludarabine, and total-body irradiation followed by …
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes [Phase 1, Phase 2]
Phase 1/Phase 2 trial of anti-MAGE-A3/12 TCR-gene engineered lymphocytes in metastatic cancers was terminated. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by biological therapy for unresectable Stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal [Phase 1, Phase 2]
This clinical trial update describes a vaccine therapy studied in patients with metastatic melanoma undergoing surgery to remove lymph nodes…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Interleukin-12 and Interferon alfa in patients with metastatic renal cell carcinoma and…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma [Phase 2]
Phase 2 trial update on modified tumor-infiltrating lymphocytes for metastatic melanoma; trial status is terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients [Phase 2]
Phase 2 clinical trial evaluating anti-MART-1 F5 lymphocytes for high-risk melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma [Phase 3]
Phase 3 trial comparing trametinib (GSK1120212) to standard chemotherapy in patients with advanced or metastatic BRAF V600E/K-mutant melanom…